One of the most common questions we hear from patients considering ketamine infusion treatments in Kennewick, WA is deceptively simple: how fast does it work? The answer matters enormously to people who have spent months or years cycling through treatments that required weeks to show any effect — and sometimes never did. Understanding what the research says about ketamine’s timeline, and how that translates to what patients experience at our clinic, is worth laying out clearly.
Why Ketamine’s Speed Is Clinically Significant
Standard antidepressants — SSRIs and SNRIs — typically require four to six weeks at therapeutic doses before patients notice meaningful symptom relief. For someone in the grip of severe depression, treatment-resistant anxiety, or PTSD, that lag is not a minor inconvenience. It represents weeks of continued suffering while waiting to find out whether a medication will even work.
Ketamine operates through a fundamentally different mechanism: rather than gradually modulating serotonin or norepinephrine levels over time, it acts on NMDA receptors in the glutamate system — the brain’s primary excitatory neurotransmitter network — producing rapid neurological changes that can translate to symptom relief within hours to days of the first infusion (Murrough et al., 2013). Research from the National Institute of Mental Health shows that ketamine restores pleasure-seeking behavior ahead of other antidepressant actions, suggesting it targets core depression symptoms more quickly than conventional treatments (NIMH, 2014). That speed is not incidental — it reflects a genuinely different mechanism of action rather than simply a faster version of the same approach.
The Initial Series: What the First Two Weeks Look Like
At Tri-Cities Infusion & Wellness Clinic, patients receiving ketamine for depression treatment in Kennewick, WA, anxiety, PTSD, or migraines typically begin with a series of six infusions over approximately two weeks. This structured approach is grounded in research showing that repeated ketamine infusion sessions produce cumulative antidepressant benefits and extend remission periods compared to a single infusion (Phillips et al., 2019). A single infusion may produce a noticeable shift, but the clinical evidence supports a full induction series for more durable results.
Each infusion runs either one hour at $350 or two hours at $500, depending on what is clinically appropriate for a given patient. Before the first infusion, every patient completes a free consultation — a review of medical history, current medications, and overall health picture — to confirm that ketamine is the right fit. We ask that patients fast for eight hours before each session, though clear liquids and black coffee without sugar or cream are permitted up to two hours prior. Patients should take their regular medications as usual, with the exception of benzodiazepines — a class of anti-anxiety medications that can interfere with ketamine’s mechanism.
On the day of an infusion, patients settle into a private room with a comfortable recliner. During the session, some people experience a floating sensation, mild hypersensitivity to light or sound, or transient visual changes — effects our team is trained to manage with verbal reassurance or, when needed, medications administered through the IV such as Zofran for nausea or Versed for anxiety. Our certified registered nurse anesthetists — Tyler Thornock and Ben Clark — lead our ketamine program, bringing extensive clinical anesthesia backgrounds to every session. The recovery period follows the infusion before discharge, and patients must arrange a driver home — they should not drive or make major decisions for at least 12 hours after treatment.
Chronic Pain: A Different Protocol
For patients receiving ketamine for chronic pain conditions, fibromyalgia, or other neurogenic pain disorders — meaning pain that originates from dysfunction in the nervous system — the protocol differs from the mental health series. Pain patients typically receive four to six infusions over a compressed four-to-seven-day period, rather than spread across two weeks. The rationale is different: chronic pain management with ketamine often focuses on interrupting central sensitization — the state in which the nervous system has become hyperresponsive to pain signals — and a denser initial schedule may be more effective for that goal. Booster infusions are then scheduled as needed based on how a patient responds.
Results vary by individual across both protocols, and we make no promises about outcomes. What we can say is that the structure is not arbitrary — it reflects what the clinical evidence supports for each application.
After the Initial Series: Boosters and Maintenance
A single course of ketamine is not necessarily the end of the conversation. Research on single, repeated, and maintenance ketamine infusions shows that booster sessions can extend the duration of benefit and help patients maintain the gains made during the initial series (Phillips et al., 2019). For mental health applications, we typically recommend reassessing patients six to twelve weeks after the initial series and scheduling boosters as needed based on how they are feeling and how their symptoms have evolved.
This ongoing relationship is part of how ketamine therapy works in practice. Some patients find that a single induction series produces lasting relief; others benefit from periodic boosters as part of a longer-term management strategy. We discuss this openly with every patient after the initial series is complete — there is no single right answer, and the plan is adjusted based on individual response. For a broader look at what the evidence says about how this therapy operates, our Ketamine Facts page offers a useful reference.
Addressing the Barriers We Hear Most
Uncertainty about whether it will work. This is the honest concern underneath most of the questions we get about timelines, and it deserves a direct response. The research is meaningful — ketamine’s rapid-acting antidepressant effects are well-documented, and the NIMH and other major research institutions have recognized it as a genuine advance in treatment for patients who have not responded to conventional options (NIMH, 2024). What we cannot do is guarantee that it will work for any specific individual. What we can do is be transparent about what the evidence shows, conduct a thorough pre-treatment evaluation, and structure treatment in a way that gives patients the best clinical opportunity to respond.
The financial side. Each one-hour infusion is $350; two-hour infusions are $500. A standard six-infusion mental health series therefore runs between $2,100 and $3,000 depending on infusion length. We accept Asuris, Providence Health Plan, Cigna, Premera, LifeWise, and First Choice Health, and coverage for ketamine varies by plan — we encourage patients to reach out before scheduling so we can help clarify what their insurer may cover. For patients with Medicare or Medicaid, we provide documentation and invoices that can be submitted for potential direct reimbursement. Zero percent financing is available through Advance Care for patients who need a payment option.
Frequently Asked Questions
How soon after my first ketamine infusion might I notice a difference? Many patients report noticing a shift within hours to a couple of days after the first infusion — a reduction in the heaviness of depression, a loosening of anxiety’s grip, or a sense of clarity that has been absent for some time. That said, individual response varies significantly, and some patients notice change more gradually over the course of the initial series rather than after a single session.
What happens if I don’t respond after the first few infusions? We monitor every patient’s response throughout the initial series and check in between sessions. If response is limited after the early infusions, we discuss whether adjusting the approach makes sense — including dose adjustments within clinically appropriate ranges. Not every patient responds to ketamine, and we will be direct with you if the evidence from your infusions suggests it may not be the right fit.
Do I need to take time off work during the two-week series? You cannot drive or make major decisions for at least 12 hours after each infusion, so scheduling needs to account for that. Many patients arrange infusions in the afternoon or evening and take the following morning off. Some patients find the dissociative effects of the infusions — the floating sensation, the altered perception — make it easier to take a full day. We can talk through scheduling logistics during your consultation.
Will my results last after the initial series ends? Durability varies by individual. Some patients maintain meaningful benefit for months after the initial series; others benefit from booster infusions at regular intervals. The research supports maintenance infusions as a strategy for extending remission, and we discuss what ongoing care looks like based on each patient’s response.
Key Takeaways
- Ketamine can produce antidepressant and anti-anxiety effects within hours to days of the first infusion — a timeline dramatically different from the four-to-six-week lag typical of SSRIs and SNRIs.
- The standard mental health and migraine protocol at our clinic is six infusions over approximately two weeks; chronic pain protocols typically run four to six infusions over four to seven days.
- Each one-hour infusion is $350; two-hour infusions are $500. Zero percent financing is available through Advance Care.
- Booster infusions at six to twelve week intervals can extend the benefit of the initial series; the need for maintenance is assessed individually based on patient response.
- Results vary by individual — a thorough pre-treatment evaluation and ongoing monitoring are built into our protocol.
The timeline question is really a question about hope — whether there is a reasonable path to feeling different than you do right now, and how long that path might take. If you have been through conventional treatments without adequate relief and are ready to have a direct conversation about what ketamine may offer, reach out to our team at Tri-Cities Infusion & Wellness Clinic. Call us at 509-383-8760 or schedule a free consultation in Kennewick today.
References
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Mathew, S. J. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression. American Journal of Psychiatry, 170(10), 1134–1142. https://pubmed.ncbi.nlm.nih.gov/23982301/
Phillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019). Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial. American Journal of Psychiatry, 176(5). https://psychiatryonline.org/doi/10.1176/appi.ajp.2018.18070834
National Institute of Mental Health. (2014). Rapid agent restores pleasure-seeking ahead of other antidepressant action. https://www.nimh.nih.gov/news/science-updates/2014/rapid-agent-restores-pleasure-seeking-ahead-of-other-antidepressant-action
National Institute of Mental Health. (2024). New hope for rapid-acting depression treatment. https://www.nimh.nih.gov/news/science-updates/2024/new-hope-for-rapid-acting-depression-treatment
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine infusion therapy should only be pursued under the supervision of a qualified healthcare provider familiar with your full medical history, current medications, and prior treatment experience. Individual results vary — timelines and outcomes are not guaranteed, and ketamine is not appropriate for every patient. This content is not a substitute for a professional medical evaluation or consultation. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.
